Centrally Adjudicated Heart Failure Outcomes Are Needed in Clinical Trials
JACC Heart Fail
.
2023 Apr;11(4):418-421.
doi: 10.1016/j.jchf.2023.01.028.
Authors
Akshay S Desai
1
,
Mark C Petrie
2
Affiliations
1
Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA. Electronic address: adesai@bwh.harvard.edu.
2
BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.
PMID:
37019557
DOI:
10.1016/j.jchf.2023.01.028
No abstract available
Keywords:
SGLT2 inhibitor; clinical trials; event adjudication; heart failure.
Publication types
Editorial
Comment
MeSH terms
Diabetes Mellitus, Type 2*
Heart Failure* / drug therapy
Humans